EARLY CONFIRMED TOP INDUSTRY Speakers
Jeonghoon Ahn, Director, National Evidence-based Healthcare Collaborating Agency
John Alter, Vice President Pricing And Market Access, Pfizer
Mauricio Alvarez Reyes, Market Access Expert, Independent
Sofie Alverlind, Project Manager, Swedish Association of Local Authorities and Regions
Francis Arickx, Head Of The Directorate Reimbursement Of Medicines And Pharmaceutical Policy, National Institute for Health and Disability Insurance RIZIV-INAMI
Ramesh Arjunji, Senior Director Heor And Rwe, AveXis
Nadeem Ashraf, Medical Advisor - Diabetes, N/A
Kagan Atikeler, Pricing Reimbursement Expert, Turkish Medicines and Medical Devices Agency
Inge Bliestle, Chief Operating Officer, TolerogenixX
Nadia Bodkin, Rare Disease Advocacy Professional, Rare Advocacy Movement
Axel Boehnke, Director Market Access (Global Responsibility), PTC Therapeutics
Luc Boileau, Chairman and Chief Executive Officer, Inesss
Anjan Chatterjee, Global Head Of Real World Evidence, Boehringer Ingelheim Pharma GmbH & Co. KG
Francis Crawley, Executive Director, Strategic Initiative For Developing Capacity In Ethical Review (Sidcer), Good Clinical Practice Alliance (GCPA)
Omar Dabbous, Vice President Health Economics And Outcomes Research, AveXis
Valentin Dodonov, Deputy General Head Of Market Access, BIOCAD
Jenny Ebert, National Account Director, Genzyme Sanofi Corp
Martina Flammer, Senior Vice President, Head Of Corporate Customer Value, Boehringer-Ingelheim
Oliver Gassner, Head Digital Health Intelligence | Emea, Bayer
Birgit Holz, Global Head Of Contracting Innovation, Sanofi
Patrick Hopkinson, Executive Director, Wwheor Markets, Bristol-Myers Squibb
Nigel Hughes, Scientific Director, RMEDS Quantitative Sciences,, Janssen
Wills Hughes-Wilson, Head Of Patient Access And Commercial Planning, Mereo BioPharma
Ulrike Jacobi, Head Of External Affairs And Market Access, Amgen
David Jakouloff, Global Head Of Market Access, Dmd, PTC Therapeutics
Wendy Jory, Head Of Global Pricing Centre Of Excellence, GlaxoSmithKline
Navin Joshi, Global Head of Pricing, Classic & Established Products. Global Pharma, Head of Pricing & Access Capabilities, Emerging Markets, GlaxoSmithKline
Lisette Kaskens, Global Head Of Pricing And Market Access, Ferrer
Jolanda Koenders, Head Of Pricing And Market Access Pharma, Novartis
Adam Kundzewicz, Senior Global Payer Strategy Manager, Head Of Pricing, Boehringer Ingelheim Pharma GmbH & Co. KG
Marie-Liesse Le Corfec, Global Portfolio Marketing Head, Ps, B.D. Pharmaceuticals Systems
Sandy Leonard, Vice President Of Medical Evidence And Observational Research, AstraZeneca
Friedhelm Leverkus, Director Health Technology Assessment And Outcomes Research, Pfizer
Mark Macgregor, Co-Vice Chair, Scottish Medicines Consortium, Nhs Scotland
Joerg Mahlich, Head Heor, Janssen Pharmaceutical K.K.
Andrea Mantovani, Market Access Expert, Independent
Anne Marciniak, Head Of Market Access, Europe, Aimmune
Tal Morginstin, Director, Nlhs (National List Of Health Services) Assessment Division, Ministry of Health
Thomas Mueller, Head Of Directorate General 1 "Drugs, Medical Devices, Biotechnology", Federal Ministry of Health Germany
Diane Munch, Head Of Global Pricing, Patient And Health Impact, Pfizer
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Alexander Natz, Secretary General, European Confederation of Pharmaceutical Entrepreneurs (Belgium)
Enkeleida Nikai, Head Of Real World Evidence, Senior Director At Janssen Europe, Middle East And Africa (Emea), Janssen Pharmaceutical
Waldemar Ockert, Director, Rwi Business Market Analytics, Astellas Pharma
Irina Odnoletkova, Vice President Health Technology Assessment, Apogenix Gmbh
Laura O'Hanlon, Associate Director, International Market Access/Reimbursement, Myriad genetics
Melvin Olson, Global Head Rwd Strategy And Innovation, Novartis Pharma
Melissa Paige, Uva Cancer Center, Oncology Patient Access Principal Coordinator, Patient Advocate, U.V.A. Health System
Elena Panitti, Global Rwe Capability Building Lead, Novartis
Detlev Parow, Head Pharmaceutical Department, D.A.K.
Chris Pashos, Vice President Of Global Evidence Strategy, AbbVie
Marco Penske, Head Of Market Access And Health Care Affairs, Boehringer-Ingelheim
Lara Pippo, Head Of Market Access, CSL Behring
Diann Potestio, Vice President Market Access, Ascendis Pharma
Marco Rauland, Vice President, Map Gmande And Training Academy, Global Market Access And Pricing, Biopharma| Global Operations, Merck Group
Kevin Rieger, Head Of Eu Affairs, BPI
Giuseppe Rosano, Member Of The Cardiovascular Working Party, European Medicines Agency
Ryan Saadi, Vice President, Global Market Access, CSL Behring
Steve Sandor, Vice President, Market Access And Trade, Paratek Pharmaceuticals , Inc.
Gustavo Saraiva Dos Anjos, Head Of Market Access, Respiratory Pipeline, GlaxoSmithKline
Anindita Sinha, Director, Global Market Access, Pfizer
Anastasiya Stepanova, State Authorities Manager, JSC Nizhpharm
Samuel Taylor, Emerging Markets Pricing Lead, Pfizer
Gwilym Thompson, Director Worldwide Heor, BMS
Daria Tolkacheva, Head Of Health Economics, JSC BIOCAD
Jorg Tomeczkowski, Head Of Market Access, Janssen Cilag Germany
Keiko Tone, Vice President Global Market Access, Shionogi Inc
Ariella Toren, Director Of Medicine And Medical Technologies, Hmos Department, Israel - Ministry Of Health
Bart Van Den Daele, Head of External Affairs – Director Market Access, Gilead Sciences
Goedele Van Haasteren, Hta Specialist, Swiss Federal Office of Public Health
Entela Xoxi, Former Aifa, Universita Cattolica Del Sacro Cuore
Fabrizio Zucca, Director Patient Access Dach, Sobi
Contact us
To sponsor or exhibit:
Edmond Rama
+44 (0)207 092 1052
edmond.rama@terrapinn.com
To speak:
Chris Shanks
+44 (0)207 092 1151
chris.shanks@terrapinn.com
Organiser
